We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03547999
Recruitment Status : Active, not recruiting
First Posted : June 6, 2018
Last Update Posted : July 12, 2022
Bavarian Nordic
Hoosier Cancer Research Network
Bristol-Myers Squibb
Information provided by (Responsible Party):
Patrick Boland, Hoosier Cancer Research Network

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : June 2023